|
|||||
|
|
Female sexual dysfunction in urological patients: findings from a major metropolitan area in the USA |
|
| Authors: | Sammy Elsamra Michael Nazmy David Shin Harry Fisch Ihor Sawczuk Debra Fromer |
| Affiliation: | 1. Department of Urology, Warren Alpert School of Medicine, Brown University, Providence, RI, Department of Urology, University of Medicine and Dentistry of New Jersey, Newark, NJ,;2. Department of Urology, Hackensack University Medical Center, Hackensack, NJ, and;3. Department of Urology, Weill‐Cornell Medical College, New York, NY, USA |
| Abstract: | Study Type – Symptom prevalence (prospective cohort) Level of Evidence 1b OBJECTIVETo determine the prevalence of and risk factors for female sexual dysfunction (FSD) in a practice focused mainly on female urology.PATIENTS AND METHODSA modified version of the Female Sexual Function Index (FSFI) was used to assess the prevalence of FSD in 587 patients who completed the questionnaire. Logistic regression was used to identify risk factors.RESULTSThe prevalence of FSD was 63%; age, menopausal status and usage of selective serotonin reuptake inhibitors were statistically significant risk factors for FSD.CONCLUSIONSFSD is highly prevalent in this population of patients and screening female urological patients for FSD should be considered. |
| Keywords: | female sexual dysfunction female urology sexual health |